0001735831-18-000003.txt : 20180412 0001735831-18-000003.hdr.sgml : 20180412 20180412153529 ACCESSION NUMBER: 0001735831-18-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180412 DATE AS OF CHANGE: 20180412 EFFECTIVENESS DATE: 20180412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vibliome Therapeutics, Inc. CENTRAL INDEX KEY: 0001735831 IRS NUMBER: 822845964 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-310035 FILM NUMBER: 18752042 BUSINESS ADDRESS: STREET 1: 533 E. MENDENHALL STREET CITY: BOZEMAN STATE: MT ZIP: 59715 BUSINESS PHONE: 1-406-599-7987 MAIL ADDRESS: STREET 1: 533 E. MENDENHALL STREET CITY: BOZEMAN STATE: MT ZIP: 59715 FORMER COMPANY: FORMER CONFORMED NAME: Vibliome Terapeutics, Inc. DATE OF NAME CHANGE: 20180328 D 1 primary_doc.xml X0708 D LIVE 0001735831 Vibliome Therapeutics, Inc. 533 E. MENDENHALL STREET BOZEMAN MT MONTANA 59715 1-406-599-7987 DELAWARE Vibliome Terapeutics, Inc. Corporation true 2017 ROBERT GOODWIN c/o VIBLIOME THERAPEUTICS, INC. 533 E. MENDENHALL STREET BOZEMAN MT MONTANA 59715 Executive Officer Director Promoter GARY FLYNN c/o VIBLIOME THERAPEUTICS, INC. 533 E. MENDENHALL STREET BOZEMAN MT MONTANA 59715 Executive Officer Director Promoter JAMES LINFIELD c/o VIBLIOME THERAPEUTICS, INC. 533 E. MENDENHALL STREET BOZEMAN MT MONTANA 59715 Executive Officer Other Decline to Disclose 06b false 2018-01-05 false true Convertible Promissory Notes and the equity securities issuable upon conversion of such Notes false 0 1000000 113000 887000 false 3 0 0 0 false Vibliome Therapeutics, Inc. /s/ Robert Goodwin Robert Goodwin Chief Executive Officer 2018-04-12